<DOC>
	<DOCNO>NCT01459094</DOCNO>
	<brief_summary>The purpose study see absorption distribution fixed-dose Combination ( FDC ) tablet canagliflozin metformin IR affect take food healthy volunteer .</brief_summary>
	<brief_title>Effect Food Fixed Dose Combination Tablet Canagliflozin Metformin Immediate Release Healthy Volunteers</brief_title>
	<detailed_description>This open-label ( identity study drug know volunteer study staff ) , single-center study evaluate oral bioavailability ( ie , absorption distribution within body ) pharmacokinetics ( blood level ) single dose 1 fixed-dose combination ( FDC ) tablet canagliflozin metformin IR ( abbreviate 1 CANA/MET IR FDC tablet ) take healthy volunteer without food ( fast state ) food ( fed state ) . Healthy volunteer participate study randomly ( chance ) assign receive Treatment A ( 1 CANA/MET IR FDC tablet take healthy volunteer fast state ) follow approximately 14 day later Treatment B ( 1 CANA/MET IR FDC tablet take healthy volunteer feed state ) Treatment B follow approximately 14 day later Treatment A .</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Canagliflozin</mesh_term>
	<criteria>Body mass index ( BMI ) 18 30 kg/mÂ² inclusive body weight less 50 kg . History current medical illness , abnormal value hematology clinical chemistry laboratory test , abnormal physical examination , vital sign 12lead electrocardiogram ( ECG ) deem clinically significant Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Oral bioavailability</keyword>
	<keyword>Canagliflozin ( JNJ-28431754 )</keyword>
	<keyword>Metformin IR</keyword>
</DOC>